A retrospective, real-world study assessing cabozantinib in advanced osteosarcoma and Ewing sarcoma
Latest Information Update: 09 Oct 2020
At a glance
- Drugs Cabozantinib (Primary)
- Indications Ewing's sarcoma; Osteosarcoma
- Focus Adverse reactions; Therapeutic Use
- 09 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress